Francesco Iorio

Closing job ad for a postdoc in CRISPR meta-analytics and AI, from Open Targets and the Human Technopole. The role is in the Iorio Lab, salary up to 40k euros, apply by 5 October. The description reads: The Perturbation Catalogue project aims to create an online repository of data from post-perturbational experiments. You will focus on a meta-analytics project, developing computational methods for the reproducibility assessment, harmonisation and analysis or inter-study CRISPR datasets, aggregating data and developing and using innovative AI-based methods for therapeutic target prioritisation pipelines.

CLOSING: Postdoc in @francescoiorio.bsky.social's lab at @humantechnopole.bsky.social

Apply through LinkedIn by 5 October: www.linkedin.com/jobs/view/43...

#scienceJobs #AcademicSky #postdocJobs

Join us for this exciting meeting!

2nd European Cancer Dependency Map Symposium - Human Technopole The 2nd European Cancer Dependency Map Symposium is a scientific event open to the national and international scientific community working in computational genomics, pharmacogenomics, and therapeutic ...

📢 The 2nd European Cancer Dependency Map Symposium is coming!
🗓️ 20 Nov 2025
📍 Human Technopole, Milan
Join us for a one-day dive into:
🔹 Cancer genomics
🔹 CRISPR screening
🔹 AI-driven target discovery
With the patronage of AIRC
🔗 humantechnopole.it/en/trainings...

The registration and abstract submission for the "High-Content CRISPR Screening" conference on March 18–19, 2026, in Vienna, Austria is now open! Secure your spot via the conference website... The registration and abstract submission for the "High-Content CRISPR Screening" conference on March 18–19, 2026, in Vienna, Austria is now open! Secure your spot via the conference website: https://...

Francesco will be speaking at the High-Content CRISPR Screening conference, taking place March 18–19, 2026 in Vienna 🇦🇹 alongside leading experts in CRISPR screening, functional genomics, and drug discovery
www.linkedin.com/posts/myllia...

10 September 2025

Join Us! @ioriolab.bsky.social

Today we bid farewell to our postDoc @aurorasavino.bsky.social, who is moving to an independent position at the University of Torino. Her talent dedication and collaborative spirit have left a lasting mark on our team and projects🎉
Wishing you all the best for this exciting next chapter, Aurora!
🥳🍾

#drugrekindle #drugrepurposing #aiinbiotech #smarterdrugdiscovery #healthinnovation #precisionmedicine #translationalscience #repurposetoadvance | DrugReKindle 🔄 Drug Repurposing: A Smarter Way to Unlock Therapeutic Value The current model of drug development is expensive, risky, and painfully slow. Bringing a new drug to market takes 10–15 years and over $2...

Excited to share that I’ve joined the Scientific Advisory Board of #DrugReKindle, a startup harnessing AI and computational biology to advance drug repurposing across human diseases.
Grateful to the team for the opportunity. Looking forward to the journey ahead.

www.linkedin.com/posts/drugre...

Just back from the GRC on Synthetic Lethality in Oncology: great science, deep discussion, great venue and flawless organisation. Thanks to @mgarnett.bsky.social, Benjamin Schwartz & @vazquezf.bsky.social for leading a fantastic meeting at the frontier of cancer research #SyntheticLethality #GRC

Enjoying the Gordon Conference on Synthetic Lethality in Oncology with @francescoiorio.bsky.social and @maxbillmann.bsky.social 😊 #bioinformatics #gordonConference #syntheticLethality

happy and honoured to have had a chance to deliver a lecture @bocconi.bsky.social University on AIapplications in life sciences and to share exciting projects we are developing at @humantechnopole.bsky.social-
A great opportunity to engage with a community that values innovation and forwardThinking

great work from @davidjadams.bsky.social out now in @natgenet.nature.com (with a computational contribution from the @ioriolab.bsky.social @humantechnopole.bsky.social led by A.Vinceti)

Proud to announce that the 2nd European Cancer DepMap Symposium has the patronage of AIRC: the Italian Association for Cancer Research. Honoured by their support as we bring together leading scientists on cancer-dependencies functional-genomics CRISPR
🔗 humantechnopole.it/en/trainings...
#EuroDepMap

we are at #EACR2025 with two posters - the second one is presented by Ludovica Proietti and Gianluca vozza and focuses on our ERC funded DEPshock project
@humantechnopole.bsky.social

we are at #EACR2025 with two posters, one presented by our Ottavio Croci on our collaborative work around a CRISPR based prioritisation of lncRNA vulnerabilities in multiple myeloma @humantechnopole.bsky.social

Cingratulations @diegodibi.bsky.social !! Well deserved 💪

YouTube video by Human Technopole 1st European Cancer Dependency Map Symposium

Following the success of the first European Cancer Dependency Map Symposium in 2023, we are excited to announce the 2nd edition, to be held at Human Technopole on the 20th November 2025. Registration and Poster submission now open!
humantechnopole.it/en/trainings...
youtu.be/x2erCuovGvc
#EuroDepMap

🧬 Excited to announce the 2nd Euro Cancer DepMap Symposium bringing together leading minds in functional genomics, cancer vulnerabilities, AI, CRISPR and anti-cancer target discovery.📍Join us in Milan for cutting-edge science, open discussion & collaboration. #EuroDepMap #CancerResearch #CRISPR

A bibliometric review on in silico drug repurposing: Performance analysis, science mapping and text mining (2000–2023) Drug repositioning is a technique to investigate whether a drug already approved for one disease will function for another disease not included in the…

www.sciencedirect.com/science/arti... Just found out that our work on computational drug repositioning (mantra.tigem.it) among the 20 most cited articles worldwide in Scopus that are part of the collection. @francescoiorio.bsky.social

🤩 The February issue of @naturemethods.bsky.social features on its cover the research of our Giuseppe Testa Group on mosaic organoids to study the brains of multiple patients simultaneously.

Read more about the research 👉 humantechnopole.it/en/news/mosa...

The submission deadline has been extended to *8 May 2025*!
"Genome Biology is calling for submissions to our Collection on key genetic determinants and functional consequences of genome editing interventions in the context of cancer."
#CRISPR www.biomedcentral.com/collections/...

Hello, Bluesky! ☀️

We fund frontier research in Europe—bold ideas, unexpected discoveries and science that shapes the future. So it’s only fitting we’ve landed here. Sorry for being late.

Follow us for updates on ERC funding, research policy, and our grantees' discoveries.

SKI complex loss renders 9p21.3-deleted or MSI-H cancers dependent on PELO - Nature Analysis of large-scale CRISPR screening data, combined with experiments in patient-derived tumour organoid models, identifies PELO as a potential therapeutic target in chromosomal 9p21.3-deleted canc...

(1/3) Excited to share our latest work using
@depmap.org to uncover a new synthetic lethality in two distinct patient populations!

We found that SKI complex inactivation through two independent genomic alterations creates a dependency on PELO

#CancerResearch #SyntheticLethality #Genomics #DepMap

Great and inspiring talk today at @humantechnopole.bsky.social delivered by Giorgio Galli from Novartis

Careers homepage Careers homepage

Probably a good time to remind my American friends that my institute here in Milan is recruiting broadly for everything from the postdoc to group leader level, and we have visa and immigration support 🇪🇺.

As the new Editor-in-Chief I encourage you to submit your work to Oncogenesis (IF 5,9) www.nature.com/oncsis/
High impact, peer-reviewed open access journal publishing articles exploring mechanistic insight and molecular basis of cancer and related phenomena.

Trump’s anti-trans Executive Order is bad BUT it technically defines everyone as female. It states:

“'Female' means a person belonging, at conception, to the sex that produces the large reproductive cell."

Since all fetuses "at conception" are female, Trump just defined EVERYONE as female.

mmm.... Your publications are not retracted after your death so technically, you don’t even need to stay alive! 😅

Following Zuckerberg’s recent announcement regarding the policy change for post moderation on Facebook and Instagram, which aligns these platforms with the same policy adopted by Musk for X/Twitter, I have decided to close my accounts also on those platforms on January 31st.

Haha, well, that does dampen my enthusiasm a little! 😅 But hey, good things take time - and I hope MANTRA is still used and useful - stay tuned for its next (much improved) version ;)